“A Randomized Study of Sofosbuvir Plus Ribavirin With and Without PEG Interferon Alpha 2b in Treatment of Hepatitis C Genotype 3 Infection: Real Life Data from a Tertiary Care Center”. 2018. International Journal of Biomedical and Advance Research 9 (3): 91-95. https://doi.org/10.7439/ijbar.v9i3.4673.